Genome editing and targeted sequence insertion with CrispR/Cas9 to elevate disease resistance in potato and tomato (JONES_S17DTP)
Genome editing and targeted sequence insertion with CrispR/Cas9 to elevate disease resistance in potato and tomato (JONES_S17DTP)
批准号:
1916145
负责人:
金额:
$0.0万
依托单位国家:
英国
项目类别:
Studentship
财政年份:
2017
资助国家:
英国
项目状态:
已结题
起止时间:
2017 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Programmable nucleases such as CrispR/Cas9 are revolutionizing biology by enabling specific genome sequences to be targeted for mutation, or for homologous recombination (HR). Such New Breeding Technologies (NBTs) can result in loss-of-function mutations, or enable precise replacement (Knock-In Exchange, or KIE) of useful genes from one plant via HR into the corresponding chromosomal position of another plant. We work with Resistance to Phytophthora infestans (Rpi) genes from wild potato and tomato relatives. The main goal of this project is to use CrispR/Cas9 (and test also the related Cpf1 programmable nuclease) to replace non-functional Rpi gene homologs in tomato and potato diploid inbred lines, with functional Rpi gene alleles. We work with inbred potato lines from www.solynta.com. Prior to targeting with KIE, resistance gene repertoires of Solanum genotypes of interest will be characterized using RenSeq with long PacBio reads (Witek et al 2016). The student will generate KIE events that (depending on NBT regulation) could be brought to market in F1 hybrids, and will interact with private and public sector breeders.Cermak T (2015) High-frequency, precise modification of the tomato genome Genome Biology 16:232 DOI 10.1186/s13059-015-0796-9 Witek (2016) Rpi gene cloning using Renseq and sMrt sequencing Nat Biot 34:656-660 www.ncbi.nlm.nih.gov/pubmed/27111721
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
基于prime editing基因编辑小鼠造血干细胞治疗重症联合免疫缺陷的研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:张璐
-
依托单位:
先导编辑技术(prime editing)在双子叶植物中的优化
-
批准号:32100327
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:鲁鹏君
-
依托单位:
prime editing基因编辑技术靶向修复MYD88突变治疗华氏巨球蛋白血症的作用及机制
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:王欣
-
依托单位:
先导编辑技术(prime editing)在双子叶植物中的优化
-
批准号:--
-
项目类别:--
-
资助金额:30万元
-
批准年份:2021
-
负责人:鲁鹏君
-
依托单位:
基因组引导编辑技术prime editing在水稻中的优化与应用
-
批准号:32001058
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:华凯
-
依托单位:
产油微藻LPCAT在正向和逆向反应中的底物特异性及其参与磷脂酰胆碱“酰基编辑”(acyl editing)的功能研究
-
批准号:31961133008
-
项目类别:国际(地区)合作与交流项目
-
资助金额:70万元
-
批准年份:2019
-
负责人:龚阳敏
-
依托单位:
受体编辑在天然自身反应性B细胞发育耐受中的作用和机制研究
-
批准号:30901336
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2009
-
负责人:邢影
-
依托单位: